The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Casale Robert Daniel since year 2005.
The trader's CIK number is 1332083.
At the time of this reporting, Casale Robert Daniel is the Chief Operating Officer of
Adams Respiratory Therapeutics, Inc.
(stock ticker symbol ARXT).
Stock purchases, sales, and option exercises reported by Casale Robert Daniel since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-12-26
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-12-26
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
59.68
179,040
2007-11-26
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-11-26
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
42.18
126,540
2007-10-25
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
40.57
121,710
2007-10-25
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-09-25
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-09-25
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
38.26
114,780
2007-08-27
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-08-27
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
36.53
109,590
2007-07-25
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-07-25
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
39.25
117,750
2007-06-25
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-06-25
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
40.51
121,530
2007-05-25
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-05-25
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
39.99
119,970
2007-04-25
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-04-25
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
37.60
112,809
2007-04-04
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
3,000
1.42
4,260
2007-04-04
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
3,000
35.00
105,000
2007-03-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2007-03-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
35.75
71,500
2007-02-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2007-02-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
44.88
89,756
2007-01-03
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2007-01-03
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
40.87
81,740
2006-12-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
39.31
78,626
2006-12-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-11-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-11-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
42.72
85,433
2006-10-02
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-10-02
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
36.06
72,126
2006-09-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
40.61
81,220
2006-09-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-08-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-08-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
42.95
85,900
2006-07-03
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
44.09
88,180
2006-07-03
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-06-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
46.01
92,025
2006-06-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-05-01
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-05-01
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
42.47
84,940
2006-04-03
ARXT
Adams Respiratory Therapeutics, Inc.
Option Exercise
2,000
1.42
2,840
2006-04-03
ARXT
Adams Respiratory Therapeutics, Inc.
Sale
2,000
39.31
78,620
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Casale Robert Daniel
(Chief Operating Officer of Adams Respiratory Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.